Exane Derivatives Alcon Inc Put Options Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
Put Options
3 transactions
Others Institutions Holding ALC
# of Institutions
730Shares Held
242MCall Options Held
2.35MPut Options Held
1.65M-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.72 Billion0.04% of portfolio
-
Credit Suisse Ag Zurich, V815.5MShares$1.37 Billion1.27% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL12MShares$1.07 Billion0.32% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA11.9MShares$1.05 Billion2.3% of portfolio
-
Harding Loevner LP Bridgewater, NJ9.27MShares$824 Million5.43% of portfolio
About ALCON INC
- Ticker ALC
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 490,087,008
- Market Cap $43.5B
- Description
- Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...